Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-04 Purchase | 2022-01-04 3:19 pm | Virios Therapeutics Inc. | VIRI | Thomas John C Director | 1,000 | $5.65 | $5,650 | 1,000 (Direct) | View |
| 2020-12-10 Sale | 2020-12-11 4:20 pm | NantKwest Inc. | NK | Thomas John C Director | 42,592 | $10.83 | $461,122 | 221,363 (Indirect Direct) | View |
| 2020-08-19 Sale | 2020-08-21 4:38 pm | NantKwest Inc. | NK | Thomas John C Director | 20,000 | $9.19 | $183,800 | 263,955 (Indirect Direct) | View |
| 2020-08-11 Sale | 2020-08-13 7:13 pm | NantKwest Inc. | NK | Thomas John C Director | 60,000 | $9.7274 | $583,642 | 283,955 (Indirect Direct) | View |
| 2019-12-13 Sale | 2019-12-16 7:40 pm | NantKwest Inc. | NK | Thomas John C Director | 30,000 | $2.8667 | $86,000 | 343,955 (Indirect Direct) | View |
| 2019-12-12 Sale | 2019-12-12 6:29 pm | NantKwest Inc. | NK | Thomas John C Director | 10,000 | $1.9918 | $19,918 | 373,955 (Indirect Direct) | View |
| 2019-09-05 Sale | 2019-09-09 4:42 pm | NantKwest Inc. | NK | Thomas John C Director | 24,000 | $1.2412 | $29,790 | 383,955 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-26 Option Award | 2024-02-28 1:09 pm | N/A 2034-02-26 | Virios Therapeutics Inc. | VIRI | Thomas John C Director | 4,167 | $0 | 4,167 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 2:01 pm | N/A 2033-06-15 | Virios Therapeutics Inc. | VIRI | Thomas John C Director | 5,250 | $0 | 5,250 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-30 2:01 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Thomas John C Director | 5,250 | $0 | 5,250 (Direct) | View |
Ownership | 2022-01-28 4:29 pm | N/A N/A | ImmunityBio Inc. | IBRX | Thomas John C Former Director Director | 0 | $0 | 216,363 (Indirect) | View |
| 2021-02-23 Ownership | 2022-01-28 4:29 pm | N/A N/A | ImmunityBio Inc. | IBRX | Thomas John C Former Director Director | 5,000 | $0 | 216,363 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 2:52 pm | N/A 2031-06-22 | Virios Therapeutics Inc. | VIRI | Thomas John C Director | 7,875 | $0 | 7,875 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-11 6:25 pm | N/A 2030-06-10 | NantKwest Inc. | NK | Thomas John C Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 4:47 pm | N/A N/A | NantKwest Inc. | NK | Thomas John C Director | 92,592 | $0 | 407,955 (Direct) | View |